- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MDGL
Recent news which mentions MDGL
Wall Street Thinks Madrigal Pharmaceuticals Could Climb 93%. Here's Why It Could Happen Soon.
September 27, 2023
Tickers
MDGL
From Motley Fool
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
From Benzinga
1 Beaten-Down Stock That Could Soar by 86%, According to Wall Street
September 20, 2023
Tickers
MDGL
From Motley Fool
The Latest Analyst Ratings for Madrigal Pharmaceuticals
September 11, 2023
Tickers
MDGL
From Benzinga
Smucker, FuelCell Energy, Granite Ridge Resources And Other Big Stocks Moving Lower On Monday
September 11, 2023
From Benzinga
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
From InvestorPlace
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of
August 30, 2023
From InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
August 30, 2023
From InvestorPlace
From Motley Fool
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
August 23, 2023
From Motley Fool
From MarketWatch
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
August 02, 2023
From Motley Fool
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
From Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
From Benzinga
From MarketWatch
2 Growth Stocks That Doubled in 2023 and Could Shoot 55% to 87% Higher, According to Wall Street
May 30, 2023
From Motley Fool
From Benzinga
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Viking Therapeutics Outperforms Expectations: Analyst Increases Price Target Following Successful VK2809 Trial
May 16, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
From Benzinga
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
From Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
5 Best Stocks to Buy in April
April 01, 2023
From Motley Fool
From Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
March 27, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.